In medical news:

A new report published in JAMA indicates that buprenorphine implants are “noninferior, and may be more effective than sublingual dosing [oral] for helping opioid-dependent adults maintain abstinence.” The Mount Sinai -based researchers note that the rate of response was 8.8 percent greater among patients who had implants than among those who used sublingual dosing. Further, switching from sublingual dosing to implants did not lead to increased craving or withdrawal symptoms.

Read more via Pain Medicine News here.

Leave a Comment

Your email address will not be published.